AHA issues ICD-10 countdown checklist

With just over a month to go until the Oct. 1 ICD-10 deadline, the American Hospital Association (AHA) has released a checklist of key steps that hospitals should take to ensure a successful transition.

AHA’s ICD-10 “homestretch” checklist for hospital leaders covers three critical areas: checking internal systems, verifying external partner readiness and considering financial protections.

Internally, AHA recommends that hospital leadership evaluate their staffing and estimate whether coding productivity will drop and by how much. Some hospitals may need additional staff in the short term to manage the transition.

AHA advises hospitals to establish communication plans with outside organizations, such as collecting emergency contact information for Medicare contractors and commercial insurers in case of delayed claims. Hospitals also should know their major trading partners’ rules and process for submitting replacement claims if they identify a coding problem that needs to be corrected.

AHA recommends hospitals familiarize themselves with their trading partners' policies and processes regarding advance payments should they experience payment delays, as well as establish credit lines that can be used if processing delays adversely affect the normal revenue cycle. The Centers for Medicare & Medicaid Services also has procedures for payment advances from Medicare in the event of financial difficulties due to a lag in Medicare billing and/or payments.

Access the AHA ICD-10 checklist.

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.